Generic Health, the Australia based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin), headquartered in India, has entered into a definitive agreement under which Lupin will acquire 100% of the shares of Southern Cross Pharma Pty Ltd (SCP).